key: cord-0688637-l0abj3ya authors: da Costa, Clauber Henrique Souza; de Freitas, Camila Auad Beltrão; Alves, Cláudio Nahum; Lameira, Jerônimo title: Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants date: 2022-05-20 journal: Sci Rep DOI: 10.1038/s41598-022-12479-9 sha: 2b85b2b1339a9603b7393d575e6548ed9f8b75cd doc_id: 688637 cord_uid: l0abj3ya The severe acute respiratory syndrome (SARS) coronavirus 2 (CoV-2) variant Omicron spread more rapid than the other variants of SARS-CoV-2 virus. Mutations on the Spike (S) protein receptor-binding domain (RBD) are critical for the antibody resistance and infectivity of the SARS-CoV-2 variants. In this study, we have used accelerated molecular dynamics (aMD) simulations and free energy calculations to present a systematic analysis of the affinity and conformational dynamics along with the interactions that drive the binding between Spike protein RBD and human angiotensin-converting enzyme 2 (ACE2) receptor. We evaluate the impacts of the key mutation that occur in the RBDs Omicron and other variants in the binding with the human ACE2 receptor. The results show that S protein Omicron has stronger binding to the ACE2 than other variants. The evaluation of the decomposition energy per residue shows the mutations N440K, T478K, Q493R and Q498R observed in Spike protein of SARS-CoV-2 provided a stabilization effect for the interaction between the SARS-CoV-2 RBD and ACE2. Overall, the results demonstrate that faster spreading of SARS-CoV-2 Omicron may be correlated with binding affinity of S protein RBD to ACE2 and mutations of uncharged residues to positively charged residues such as Lys and Arg in key positions in the RBD. www.nature.com/scientificreports/ infectivity 38 . The RBD of S1 undergoes conformational changes that transiently conceal or reveal the determinants of receptor binding 24, 39 . The Spike (S) protein of SARS-CoV-2 consists in an extracellular N-terminus, a transmembrane (TM) domain and a intracellular C-terminal segment 40 . S protein has a total length of 1273 amino acids 35 and molecular weight of 180-200 kDa 41 . It has a signal peptide (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) at the N-terminus, followed by S1 subunit and the S2 subunit (686-1273) 35 . The structure of the RBD allows for ways to alter its genetic material, developing variants by the changes in Spike protein amino acids and as viruses replicate 16 , copying errors of itself, resulting in mutations that arise in their genomes generating several strains of SARS-CoV-2 17, 42 that differ in transmission, infectivity and severity of the disease 42 . ACE2 primary physiological role is in the maturation of angiotensin (Ang) 43 , a peptide hormone that controls vasoconstriction and blood pressure, is a type I membrane protein expressed in lungs, heart, kidneys, and intestine 25, 44 , thereat, decreased expression of ACE2 is associated with cardiovascular diseases 45 . The structural features of RBD increase its binding affinity to the ACE2 receptor and it is a significant step for SARS-CoV-2 to enter into target cells 33, 46 . Computer modelling studies of the interaction between the SARS-CoV-2 RBD and ACE2 were able to identify the residues involved in this interaction and elucidate how the structural change benefits receptor recognition and virus entry into the host cell, that occurs by proteolytic processing of the Spike protein to promote cell-virus fusion 47 . Therefore, atomic details may clarify the importance and significance of investigating the changes in residues that facilitate efficient cross-species infection and human-to-human transmission 34 . Whereas the essential evolution and consequent mutation of SARS-CoV-2 takes place remotely from the RBD in the Spike protein, such evolution may facilitate the conformational change in specific residues, punctually interfering with the infection process that occurs after the virus binds to ACE2 48 . Recently, Warshel and co-workers studied the mechanism of the binding affinity changes for mutations at different Spike protein domains of SARS-CoV-2, Alpha, Beta and Delta variants using coarse-grained potential surface to calculate the binding free energy of SARS-CoV-2 to ACE2 49 , concluding that the evolution of the virus takes place from the binding domain in the trimeric body of the Spike protein, which may facilitate the conformational change and the infection process. Chen and co-workers used machine learning model to analyze how the RBD mutations on the Omicron variant may affect the viral infectivity and efficacy of existing vaccines and antibody drugs 50 . They results indicated that the Omicron variant may be ten times more contagious than the Wild Type (WT) virus or about twice as infectious as the Delta variant, also based on the Spike protein binding domain 50 . More recently, Kumar and co-workers 51 molecular dynamics (MD) simulations to investigate the interaction between the RBD of both the WT and Omicron variant with the ACE2 receptor and found that the Omicron Spike protein has an increased affinity for the ACE2 receptor, due to the presence of mutant residues 51 . Similarly, Socher and coworkers have used MD simulations of the RBD and ACE2 to analyze and compare the interaction pattern between the WT, Delta and Omicron variants, where they have identified residue 493 in Delta (glutamine) and Omicron (arginine) with altered binding properties towards ACE2 52 . MD simulation have also been used to explore the effect of different possible mutations of the Spike key residues, which are the mutations found in the most relevant observed variants 53 . In this study, we have used all-atom accelerated molecular dynamics (aMD) simulations 54, 55 to explore the impacts of the substitutions that occur in the Spike RBD of Alpha, Delta and Omicron variants in the binding with the human ACE2 receptor. In order to address the question whether variant infectivity and spreading is related to its binding to the receptor. SARS-CoV-2 Spike protein is a class I fusion homotrimer glycoprotein that is composed a total length 1273 residues 56 and the binding between the virus and the host cell is mediated by the interaction of the protein S receptor binding domain (RBD, located in the S1 domain) with the angiotensin converting enzyme receptor 2 (ACE2). Here, for the sake of simplicity, S protein RBD from SARS-CoV-2 was renamed as RBD x , where x represents the identification of each SARS-CoV-2 variant. The initial systems were built considering the coordinates of the RBD complex and the ACE2 (PDB code 6M0J) 33 . The protonation states of the protein residues were defined through the propKa program at pH 7 57 . The amino acids were treated with the ff14SB force field 58 using TLeap module included in AMBER 16 59 . Each system was solvated using TIP3P water 60 model in a cubic box with 10.0 Å of the amino acid at the end for all Cartesian directions. Then, each system was neutralized using Na + as contra-ions. We used four minimization steps with 10,000 cycles for each step, applying minimization first to water, contraions and protein, in the last step the minimization was applied to all atoms in the system in order to decrease energy, adjust interactions and decrease contacts with conjugate gradient and steepest descent. The systems were heated linearly from 0 to 300 K (tempi = 0.0; temp0 = 300.0) to avoid excessive and sudden fluctuations of the solute in a time of 5 ns in NVT ensemble employing Langevin dynamics as thermostat (collision frequency of 2 ps) had been used to guarantee a system equilibrium. The SHAKE algorithm 61 was employed to constraints all bonds involving hydrogen atoms. First, we have performed 10 ns of Classical molecular dynamics (cMD) simulations to calculate the average dihedral and total potentials energies to be taken as reference for the accelerated molecular dynamics (aMD) simulations. Then 200 ns of aMD simulations was carried out for each system: RBD WT -ACE2, RBD Alpha -ACE2, RBD Omicron -ACE2 and RBD Delta -ACE2 complex in NPT essemble. In general, dynamic properties of proteins cannot be simulated directly using molecular dynamics because of nanosecond time scale limitations 54 , since the systems are trapped in potential energy minima with high free energy barriers for large numbers of computational steps 54 . The aMD is a useful technique for enhancing the sampling during MD simulation 62, 63 . This technique is based on the reduction of energy barriers between the different states of a biological system 54 www.nature.com/scientificreports/ to state at an accelerated rate, enabling the visit of more structures at energy minima 54, [64] [65] [66] . In general, 500 ns of aMD simulation can be compared to values calculated from the 1 ms cMD simulation and the experimental values 65, [67] [68] [69] [70] . For this reason, we have used aMD technique in order to enhance sampling in the protein's conformational space, artificially reducing the energy barriers that separate different states of a given system 54, 55, [71] [72] [73] [74] . Additionally, we used the Bio3D package 75 to perform the principal component analysis (PCA). The PCs were obtained from the diagonalization of the covariance matrix obtained from the Cartesian coordinates of the superposed Cα atoms of complex structure. To avoid an underestimate of the atomic displacement, an iterated superposition procedure was applied before the PCA, where residues displaying the largest positional differences were excluded at each round until only the invariant 'core' residues remained [76] [77] [78] [79] . Protein-protein binding free energy. In this study, we also evaluated the binding energy differences between the complexes and then the decomposition energy was added to assess the energy contribution of each amino acid during the binding of RBD to ACE2. The binding free energy for the each RBD-ACE2 complex was obtained using: Here, G RBD-ACE2 represent the average over the snapshots of a single trajectory of the MD RBD-ACE2complex, G RBD and G ACE2 corresponds to the free energy of RBD and ACE2 protein, respectively. The binding free energy was obtained using MMGBSA method 80, 81 implemented in AMBER 16 59 . In order to calculate free energy with MMGBSA (Eq. 2) 5000 frames were taken from the 10 ns of MD production using 82-84 : where, E MM is total gas phase energy (sum of E internal , E electrostatic , and E vdw ); G sol is sum of polar ( G GB ) and non-polar ( G SA ) contributions to solvation. It is important to note that the entropy contribution was not included in the calculations due to the difficulty of accurately calculating entropy for a large protein-protein complex 85 . It is also worth to note that the frames were taken from the most stable structure observed in PCA graphics. Analysis of molecular dynamics of RBD-ACE2 complex. All-atom aMD simulations allowed to explore the conformations of protein-protein complex over time for each system: RBD WT -ACE2, RBD Alpha -ACE2, RBD Omicron -ACE2 and RBD Delta -ACE2 complex. Figure 1 shows the RMSD during 200 ns of aMD for each system with respect to the reference structure of the equilibrium step. RBD WT -ACE2, RBD Alpha -ACE2 and RBD Delta -ACE2 complexes were within fluctuation in a range of 1-3 Å (Fig. 1) , while the RBD Omicron -ACE2 complex the present the different variation during simulation in a range of 1-4 Å (Fig. 1) . Therefore, the structural equilibrium was reached for all system (Fig. 1) . In order to obtain insight into flexibility of each residue in protein-protein complex, we have analyzed the Root-Mean-Square Fluctuations (RMSF) taken into consideration the fluctuations of the backbone atoms. In the RMSF analysis (Fig. 2) ACE2 shows the greatest fluctuation in regions 123 to 178 (in magenta), 395 to 425 (in red) and in the region of residues 248 to 368 (in yellow), that moves to interact with the viral RBD. the RBD Alpha residues show less fluctuation compared to the WT and its last variants (Delta and Omicron). In this study, we also explore the flexible region in protein-protein complex, through essential dynamics analysis. The PCA graphs, were obtained using the combinations of PC1 vs PC2, PC2 vs PC3 and PC3 vs PC1 (Fig. S2) , in which the clusters demonstrate two possible states for all systems in PC1 vs PC2. The color scales represent the trajectory time of the MD, separating the beginning of the structures in the initial time of the final structures of the MD, however, the Alpha variant already has a greater number of clusters, where each time interval is separated into small clusters. For Omicron system the structures are visibly separated into blue structures and red structures (see SI, Fig. S2 ), indicating that the initial structures differ from the final ones, leading to variations in the aMD structures (Fig. 3) . The PCA analysis showed that the RBD WT and the RBD micron -RBD Omicron variant present greater www.nature.com/scientificreports/ conformational fluctuations, however, the RBD Alpha variant stands out for its greater stability. In PC1 there are not many movements in RBD and ACE2 (Fig. 3) . The main movement of RBD WT and RBD micron -RBD Omicron is similar because they have a greater number of movements. The Spike protein, via RBD, when it binds, causes changes in ACE2, as shown in Fig. 3 . The other conformational changes are shown in PC2 and PC3 in Fig. S3 for all systems. Binding free energy MMGBSA and decomposition by residue. To assess the affinity of the virus for the human receptor and a possible potential risk of immune evasion by the variants, we calculated the free energy using MM/GBSA [∆G bind (MMGBSA)] based on the points of greatest stability of the aMD trajectory (see Table 1 ). The RBD micron -RBD Omicron shows the highest binding affinity to ACE2, reflecting the infectivity process, but its conformational fluctuations is similar to the other variants. RBD micron -RBD Omicron present an adaptive and non-aggressive process when compared to the RBD Alpha (with free energy of binding equal to − 62.7836 kcal/ mol), which demonstrated the lower free energy than RBD WT (− 59.7205 kcal/mol). Based on the higher conformational stability of the Alpha variant the high risk is evident and demonstrates a worrying risk of immune evasion due to its degrees of affinity with ACE2. The RBD Delta has a higher binding affinity with the human receptor compared to the RBD WT (− 66.1357 kcal/ mol), which demonstrates the great concern of infections based on this variant. The high risk of infectivity is pointed out as greater among the variants because they have a more favorable ∆G bind in comparison to RBD WT . Therefore, the risk of evolution and emergence of new variants may represent a major health concern due to the degree of affinity that evolves the greater affinity for the human receptor. The effect of mutations can be investigated through the free energy calculations that track the influence of changes in certain positions 49 . The results of the energy of decomposition by residue for RBD WT -ACE2, RBD Alpha -ACE2, RBD Omicron -ACE2 and RBD Delta -ACE2 complex demonstrate that the RBD is the region that has more energy variations, attractive and repulsive, when evaluated the electrostatic contributions (see Fig. 4 , Figs. S4, S5 and S6). The evaluation of the decomposition energy per residue shows the mutations N440K, T478K, Q493R and Q498R observed in RBD Omicron provide favorable interaction between RBD Omicron and ACE2. Curiously, all these mutations include positively charged residues Lys or Arg (see Table 2 ). For example, K478 in RBD Omicron present a stabilization effect (− 85.8 kcal/mol), while T478 in RBD WT has a destabilization effect (0.7 kcal/mol), see Table 2 . Additionally, Table S2 shows the hydrogen bonds in the protein-protein interaction for the SARS-Cov-2, Alpha, Delta and Omicron system. The N501Y mutation in the RBD Alpha has a very similar contribution to the RBD WT system. This mutation does not cause such apparent changes in the energetic contributions. Therefore, its conformational stability is the main feature that contributes to the better binding of RBD Alpha to ACE2, compared to the RBD WT . The alterations in the Delta variant cause a highly attractive energy, in which the residue L352R had an energetic contribution of − 90,524 kcal/mol and T478K equal to − 82,654 kcal/mol (see Table 2 ), indicating that there is a great improvement in the binding with the receptor. The mutations present in RBD Omicron demonstrate that during the gain in the energetic contribution of the residues. Some mutations present in RBD Omicron (N440K, T478K, Q493R, Q498R) demonstrate that substitutions for positively charged residues guide an improvement in the contribution to the interaction with ACE2 (Fig. S7 ). T478K is located in a more solvent-oriented region, allowing interaction with ACE2, due to the increase in the side chain Fig. S7a . As well, the Q493R substitution allows favorable interaction with negatively charged residues of ACE2 such as Asp38 and Glu35, improving the binding with the receptor and increasing the affinity of the Spike protein (Fig. S7b) . The N440K in the micron Omicron is located in the region most focused on the solvent, increasing the contribution of this region with the medium (Fig. S7c) , whereas the Q498R substitution improves the protein-protein interaction since this contribution is 24 times greater in relation to the WT, demonstrating that these substitutions are essential for improving interaction with ACE2 (Fig. S7d) . A recent study has suggested that RBD Omicron present a slightly reduced binding to ACE2 compared to RBD WT (RBD of the original Wuhan strain) 86 and RBD Delta . The EC 50 values were determined to be 120, 150 and 89 ng/ mL for RBD WT , RBD Omicron and RBD Delta , respectively 86 . Other experimental study have proposed that RBD Omicron shows weaker binding affinity than RBD Delta to ACE2 87 . Han and coworkers have measured the binding affinities of the RBDs to ACE2 with surface plasmon resonance (SPR) assay 88 . They found that RBD WT , RBD Omicron and RBD Delta binds to ACE2 with a dissociation constant (K D ) of 24.63 nM, 31.40 and 25.07. Other experimental study shows that RBD Omicron and RBD Delta binds to ACE2 at a similar affinity to that of the RBD WT 89 . www.nature.com/scientificreports/ www.nature.com/scientificreports/ On the other hand, Lin and coworkers have obtained kinetic-affinity values of 87.9 nM for RBD WT and 40.8 nM for RBD Omicron . These values highlight ~ 2.2-fold-enhanced receptor-binding with RBD Omicron 90 . A recent computational study have investigated the interaction between the RBD of both the WT and Omicron variant of SARS-CoV-2 with the ACE2 receptor using molecular dynamics and molecular mechanics-generalized Born surface area (MM-GBSA)-based binding free energy calculations 51 . Authors have carried out 100 ns of MD simulations for each complex and have suggested that the RBD Omicron has an increased affinity for the ACE2 receptor in comparison to RBD WT 51 . This last study has a closer relationship to our strategy used in here. The main difference is that we are describing computational result from 200 ns of aMD to explore molecular details interactions that occur in the Spike RBD of Alpha, Delta and Omicron variants in the binding with the ACE2 receptor. It is important to note that some bioinformatic models predicted an increase in the ACE2 binding affinity of RBD Omicron 91 . Here, our results are suggesting that complexes studied have similar fluctuations and that mutations present in RBD Omicron , RBD Delta and RBD Alpha increase the binding to ACE2 compared to RBD WT . In this study, we evaluated the effect of residues mutation on structural and energetics of Spike protein RBD from SARS-CoV-2 variants in complex with the human ACE2 receptor. All-atoms accelerated Molecular Dynamics simulations and PCA analysis shows that that the RBD Omicron -ACE2 complex present similar fluctuation in comparison to S protein from WT, Delta and Alpha variants. The binding affinity of each RBD x to ACE2 was obtained using MM-GBSA methods. The results show that the trend in the calculated binding free energies correlates well with virus infectivity of each variant. The mutation in RBD Omicron increase the affinity of Spike protein for ACE2 and may explain Omicron's high transmissibility in comparison with other SARS-CoV-2 variants. The stabilization effect RBD Omicron -ACE2 complex is achieved manly due the substitution of uncharged residues by positively charged residues: Lys and Arg in key positions. Overall, our results may explain at molecular level the effect of key mutations in the Spike protein for virus infectivity. All necessary files to conduct this work (.pdb and .parm7) can be found attached as the Supporting Information. The AMBER18 suite of programs and the Amber ff14SB force field were used to carry out the MD simulations and can found at https:// amber md. org/. www.nature.com/scientificreports/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Clinical features of patients infected with 2019 novel coronavirus in Wuhan World Health Organization. Coronavirus Disease (COVID-19) Outbreak (World Health Organization A new coronavirus associated with human respiratory disease in China A novel coronavirus from patients with pneumonia in China Economic and social impacts of COVID-19 and public health measures: Results from an anonymous online survey in Thailand The impact of the COVID-19 pandemic on social, health, and economy World Health Organization. COVID-19 Weekly Epidemiological Update 1-23 (World Health Organization Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: A narrative review High effectiveness of SARS-CoV-2 vaccines in reducing COVID-19-related deaths in over 75-year-olds, Ceará State, Brazil Vaccinations against COVID-19 may have averted up to 140,000 deaths in the United States Effectiveness of COVID-19 vaccines against Omicron or Delta infection Effect of Covid-19 vaccination on transmission of alpha and delta variants Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant Mutated COVID-19 may foretell a great risk for mankind in the future Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface World Health Organization. Classification of Omicron 11-12 (World Health Organization CoVariants: SARS-CoV-2 mutations and variants of interest Nextstrain: Real-time tracking of pathogen evolution Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method The digestive system is a potential route of 2019-nCov infection: A bioinformatics analysis based on single-cell transcriptomes Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization Evidence for a mouse origin of the SARS-CoV-2 Omicron variant The SARS-CoV-2 spike protein: Balancing stability and infectivity Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2 Molecular mechanism of the N501Y mutation for enhanced binding between SARS-CoV-2's spike protein and human ACE2 receptor Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7. Cell Rep Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor Structure of SARS coronavirus spike receptor-binding domain complexed with receptor Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19 The SARS-CoV S glycoprotein: Expression and functional characterization A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2 V367F mutation in SARS-CoV-2 spike RBD emerging during the early transmission phase enhances viral infectivity through increased human ACE2 receptor binding affinity Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor SARS-CoV-2 variants, spike mutations and immune escape A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2 Coronavirus disease 2019 (COVID-19) and cardiovascular disease: A viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection Structural basis of receptor recognition by SARS-CoV-2 Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus Critical differences between the binding features of the spike proteins of SARS-CoV-2 and SARS-CoV Predicting mutational effects on receptor binding of the spike protein of SARS-CoV-2 variants Omicron variant (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance Improved binding affinity of omicron's spike protein for the human angiotensinconverting enzyme 2 receptor is the key behind its increased virulence Molecular dynamics simulations of the delta and omicron SARS-CoV-2 spike-ACE2 complexes reveal distinct changes between both variants Inferring the stabilization effects of SARS-CoV-2 variants on the binding with ACE2 receptor Accelerated molecular dynamics: A promising and efficient simulation method for biomolecules Molecular Modeling of Proteins Site-specific glycan analysis of the SARS-CoV-2 spike Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pKa values ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB Comparison of simple potential functions for simulating liquid water A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations A method for accelerating the molecular dynamics simulation of infrequent events Hyperdynamics: Accelerated molecular dynamics of infrequent events Fast peptidyl cis-trans isomerization within the flexible Gly-rich flaps of HIV-1 protease Exploring multiple timescale motions in protein GB3 using accelerated molecular dynamics and NMR spectroscopy On the use of accelerated molecular dynamics to enhance configurational sampling in ab initio simulations Routine access to millisecond time scale events with accelerated molecular dynamics Designed replacement of an internal hydration water molecule in BPTI: Structural and functional implications of a Gly-to-Ser mutation Quantitative assessment of the energetics of dopamine translocation by human dopamine transporter Improved modeling of peptide-protein binding through global docking and accelerated molecular dynamics simulations Using accelerated molecular dynamics simulation to elucidate the effects of the T198F mutation on the molecular flexibility of the West Nile virus envelope protein Studying functional dynamics in bio-molecules using accelerated molecular dynamics Evaluation of enhanced sampling provided by accelerated molecular dynamics with Hamiltonian replica exchange methods Conformational changes of glutamine 5′-phosphoribosylpyrophosphate amidotransferase for two substrates analogue binding: Insight from conventional molecular dynamics and accelerated molecular dynamics simulations Bio3d: An R package for the comparative analysis of protein structures Assessment of the PETase conformational changes induced by poly(ethylene terephthalate) binding Computational study of conformational changes in human 3-hydroxy-3-methylglutaryl coenzyme reductase induced by substrate binding Unraveling the conformational dynamics of glycerol 3-phosphate dehydrogenase, a nicotinamide adenine dinucleotide-dependent enzyme of Leishmania mexicana On the analysis and comparison of conformer-specific essential dynamics upon ligand binding to a protein Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate-DNA helices Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models Solvent interaction energy calculations on molecular dynamics trajectories: Increasing the efficiency using systematic frame selection The Amber biomolecular simulation programs Molecular dynamics-solvated interaction energy studies of protein-protein interactions: The MP1-p14 scaffolding complex Understanding the molecular basis of MK2-p38α signaling complex assembly: Insights into proteinprotein interaction by molecular dynamics and free energy studies Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant SARS-CoV-2 Omicron RBD shows weaker binding affinity than the currently dominant Delta variant to human ACE2 Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2 SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex Characterization of SARS-CoV-2 Omicron spike RBD reveals significantly decreased stability, severe evasion of neutralizing-antibody recognition but unaffected engagement by decoy ACE2 modified for enhanced RBD binding Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) for their financial support. We also thank to the support of the Pró-Reitoria de Pesquisa e Pós-Graduação (PROPESP/UFPA), likewise, the access of the computational resources of the Supercomputer Santos Dumont (SDumont) provided by the Laboratório de Computação Científica (LNCC), Apollo 2000 and Cluster CABANO provided by the Laboratório de Planejamento e Desenvolvimento de Fármacos -Universidade Federal do Pará (UFPA). The authors declare no competing interests. The online version contains supplementary material available at https:// doi. org/ 10. 1038/ s41598-022-12479-9.Correspondence and requests for materials should be addressed to J.L.Reprints and permissions information is available at www.nature.com/reprints.Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.